Evidence map›Paper›PMID 36408146›Full record

ArticleFrontiers in oncology2022

Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience.

Vanessa Di Lalla, Sara Elakshar, Maurice Anidjar, Marwan Tolba, Toufic Hassan, Boris Bahoric, Victor McPherson, Stephan Probst, Tamim Niazi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Vanessa Di LallaDepartment of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Sara ElaksharDepartment of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Maurice AnidjarDepartment of Urology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Marwan TolbaDepartment of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Toufic HassanDepartment of Urology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Boris BahoricDepartment of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Victor McPhersonDepartment of Urology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Stephan ProbstDepartment of Nuclear Medicine, Jewish General Hospital, McGill University, Montreal, QC, Canada.
Tamim NiaziDepartment of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
McGill University · CAJewish General Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose/objectives: High-intensity focused ultrasound (HIFU) remains investigational as primary treatment for localized prostate cancer but is sometimes offered to select patients. At HIFU failure, data guiding salvage treatment is limited to small retrospective series with short follow-up. We evaluated our institutional experience using salvage radiation therapy (SRT) after HIFU failure. Materials/methods: We conducted a retrospective analysis of patients with local failure post-HIFU who received salvage image-guided external beam radiation therapy (EBRT) delivered Results: From 2013 to 2018, 12 out of 96 patients treated with primary HIFU received SRT Conclusions: To our knowledge, we report one of the largest series on contemporary SRT post HIFU failure. We show that SRT is feasible, effective and carries no additional acute or delayed toxicity.

Indexed as

high-intensity focused ultrasoundlocalized prostate canceroutcomesprostate cancer treatmentsalvage radiotherapy

Identifiers

PMID36408146
PMCPMC9669274
OpenAlexW4308419397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.